Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer
Authors:
- Larissa BahlsLBLarissa Bahls
- Roger YamakawaRYRoger Yamakawa
- Karina ZanãoKZKarina Zanão
- Daniela AlfieriDADaniela Alfieri
- Tamires FlauzinoTFTamires Flauzino
- Francieli DelonguiFDFrancieli Delongui
- André De AbreuAAAndré De Abreu
- Raquel SouzaRSRaquel Souza
- Fabrícia GimenesFGFabrícia Gimenes
- Edna ReicheEREdna Reiche
- Sueli BorelliSBSueli Borelli
- Marcia ConsolaroMCMarcia Consolaro
Open Access
- 31 August 2017
- journal article
- clinical trial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1478
Abstract
Only a small proportion of women who are exposed to infection with high-risk human papillomavirus (HR-HPV) progress to persistent infection and develop cervical cancer (CC). The immune response and genetic background of the host may affect the risk of progression from a HR-HPV infection to lesions and cancer. However, to our knowledge, no studies has been conducted to evaluate the relationship between variability of human leukocyte antigens (HLA) genes and serum cytokine expression in this pathology. In the current study, we examined the associations of HLA alleles and haplotypes including Class I (HLA-A, -B and -C) and II (HLA-DRB1, -DQA1 and -DQB1) with serum levels of cytokines interleukin (IL)-6, tumor necrosis factor-α (TNF-α), IL-10 and IL-17 as well as risks of HPV infections, lesions and CC among admixed Brazilian women. HLA polymorphisms were associated with an increased risk or protection from HPV, lesions and CC. Additionally, we demonstrated a potential association of a HLA class I haplotype (HLA-B*14-C*08) with higher IL-10 cytokine serum levels in cervical disease, suggesting an association between HLA class I and specific cytokines in cervical carcinogenesis. However, larger studies with detailed HPV types coupled with genetic data are needed to further evaluate the effects of HLA and CC by HPV genotype.Keywords
Funding Information
- This study was supported by grants from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazilian Government
This publication has 62 references indexed in Scilit:
- The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian PopulationBioMed Research International, 2013
- Role of IL-12p40 in cervical carcinomaBritish Journal of Cancer, 2012
- Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia riskCancer, 2011
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological FindingsThe Journal of Infectious Diseases, 2010
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- HPV Variants and HLA Polymorphisms: The Role of Variability on The Risk of Cervical CancerFuture Oncology, 2009
- Interaction between polymorphisms of the Human Leukocyte Antigen and HPV-16 Variants on the risk of invasive cervical cancerBMC Cancer, 2008
- Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer RiskCancer Research, 2008
- Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteriInternational Journal of Cancer, 2002
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002